Synthetic TLR2 ligand administered dramatically increases atherosclerosis in LDLR-/- mice, with TLR2 deficient bone marrow transfer into this model preventing TLR2 ligand-induced atheroma [146]. The gene discussed is LDLR; the disease is atherosclerosis.